Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.35 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.35 |
| ▸ | FUCA1 | P04066 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16743129 | 1.00 | CA1 (0.50) | CA1CA2CA4TRPA1TRPM8 | |
| SCHEMBL12572512 | 0.85 | TRPA1 (0.38) | CA1CA2CA4TRPA1TRPM8 | |
| SCHEMBL10297575 | 0.85 | CA1 (0.39) | CA1CA2CA4TRPA1TRPM8 | |
| SCHEMBL3480047 | 0.84 | CA1 (0.48) | CA1CA2CA4TRPA1TRPM8 | |
| SCHEMBL12166791 | 0.79 | CA1 (0.43) | CA1CA2CA4 | |
| SCHEMBL3480157 | 0.76 | CA1 (0.44) | CA1CA2CA4 | |
| SCHEMBL16202654 | 0.74 | MEN1 (0.35) | CA1CA2CA4TRPA1TRPM8 | |
| SCHEMBL15686712 | 0.74 | MEN1 (0.35) | CA1CA2CA4TRPA1TRPM8 | |
| SCHEMBL10289879 | 0.73 | — | — | |
| SCHEMBL622091 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260063603-A1 | PROCESS FOR DIFFERENTIATION OF HIGH-VALUE NATURAL ESSENTIAL OIL-BASED AROMA CHEMICALS FROM SYNTHETIC ANALOGUES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2026-03-05 | — | — | US | claimed |
| US-20260063603-A1 | PROCESS FOR DIFFERENTIATION OF HIGH-VALUE NATURAL ESSENTIAL OIL-BASED AROMA CHEMICALS FROM SYNTHETIC ANALOGUES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2026-03-05 | — | — | US | disclosed |
| US-20210361547-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | JPMORGAN CHASE BANK, N.A. | 2021-11-25 | — | — | US | disclosed |
| US-9072676-B2 | Cyclohexyl carbamate compounds as skin and/or hair lightening actives | SYMRISE AG (DE) | 2015-07-07 | — | — | US | disclosed |
| US-9072676-B2 | Cyclohexyl carbamate compounds as skin and/or hair lightening actives | SYMRISE AG (DE) | 2015-07-07 | — | — | US | disclosed |
| US-9012497-B2 | Cyclohexyl carbamate compounds as active anti-cellulite ingredients | SYMRISE AG (DE) | 2015-04-21 | — | — | US | disclosed |
| US-9012497-B2 | Cyclohexyl carbamate compounds as active anti-cellulite ingredients | SYMRISE AG (DE) | 2015-04-21 | — | — | US | disclosed |
| US-20130156710-A1 | CYCLOHEXYL CARBAMATE COMPOUNDS AS SKIN AND/OR HAIR LIGHTENING ACTIVES | SYMRISE AG (DE) | 2013-06-20 | — | — | US | disclosed |
| US-20130156710-A1 | CYCLOHEXYL CARBAMATE COMPOUNDS AS SKIN AND/OR HAIR LIGHTENING ACTIVES | SYMRISE AG (DE) | 2013-06-20 | — | — | US | disclosed |
| US-20130137710-A1 | CYCLOHEXYL CARBAMATE COMPOUNDS AS ACTIVE ANTI-CELLULITE INGREDIENTS | SYMRISE AG (DE) | 2013-05-30 | — | — | US | disclosed |
| US-20130137710-A1 | CYCLOHEXYL CARBAMATE COMPOUNDS AS ACTIVE ANTI-CELLULITE INGREDIENTS | SYMRISE AG (DE) | 2013-05-30 | — | — | US | disclosed |
| EP-2389922-A1 | Cyclohexyl carbamate compounds as anti-ageing actives | Symrise AG (DE) | 2011-11-30 | — | — | EP | disclosed |
| EP-1761238-A1 | MENTHOL DERIVATIVE AND COOLING AGENT COMPOSITION COMPRISING THE SAME | Takasago International Corporation (JP) | 2007-03-14 | — | — | EP | disclosed |
| WO-2005115325-A1 | MENTHOL DERIVATIVE AND COOLING AGENT COMPOSITION COMPRISING THE SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2005-12-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130156710-A1 | CYCLOHEXYL CARBAMATE COMPOUNDS AS SKIN AND/OR HAIR LIGHTENING ACTIVES | CBR1, CYP2A13, CBR3 | CA1 2601/4885CA2 929/4885CA4 893/4885 |
| US-20260063603-A1 | PROCESS FOR DIFFERENTIATION OF HIGH-VALUE NATURAL ESSENTIAL OIL-BASED AROMA CHEMICALS FROM SYNTHETIC ANALOGUES | SRMS, TRPM4, SMAD2 | CA1 2812/4885CA2 2866/4885CA4 1253/4885 |
| US-20130137710-A1 | CYCLOHEXYL CARBAMATE COMPOUNDS AS ACTIVE ANTI-CELLULITE INGREDIENTS | CBR1, NCOR2, CECR2 | CA1 2365/4885CA2 250/4885CA4 400/4885 |
| US-20210361547-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | FHIT, ALG3, FEM1B | CA1 2821/4885CA2 4435/4885CA4 2798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.